1766
M. DATTA AND A. J. BUGLASS
N-(2,4,6-Trimethylphenyl)-4-nitrobenzenesulfinamide (2a). Mp 140 ꢁC;
FTIR (KBr) nmax (cmꢀ1) 3320, 3037, 2918, 1605, 1531, 1482, 349, 1144, 1095, 1069,
1013, 854. 1H NMR (400 MHz, CDCl3) d 8.39 (dd, J ¼ 7.0, 1.7 Hz, 2H), 8.09
(dd, J ¼ 6.9, 1.7 Hz, 2H), 6.91 (s, 2H), 5.57 (bs, 1H), 2.37 (s, 6H), 2.27 (s, 3H).
13C NMR (100 MHz, CDCl3) d 152.65, 149.73, 136.54, 133.87, 133.51, 129.68,
126.78, 124.08, 20.72, 19.03. EIMS m=z (%) 304 (Mþ., 55), 170 (Mþ.– ArNH, 12),
134 (Mþ.– ArSO, 100), 119 (11), 91 (50). Anal. calcd. for C15H16N2O3S: C, 59.21;
H, 5.26; N, 9.21. Found: C, 59.23; H, 5.20; N, 9.25.
N-(4-Methylphenyl)-2,4-dinitrobenzenesulfinamide (3a). Mp 134 ꢁC;
FTIR (KBr) nmax (cmꢀ1) 3106, 3079, 2359, 1669, 1605, 1541, 1511, 1345, 1083,
1
106, 1016, 858. H NMR (400 MHz, CDCl3) d 8.96 (d, J ¼ 2.1 Hz, 1H), 8.57 (dd,
J ¼ 8.5, 2.1 Hz, 1H), 8.42 (d, J ¼ 8.5 Hz, 1H), 7.01 (d, J ¼ 8.2 Hz, 2H), 6.88 (d,
J ¼ 8.2 Hz, 2H), 5.95 (bs, 1H), 2.24 (s, 3H). 13C NMR (100 MHz, CDCl3) d
149.65, 147.60, 146.29, 136.03, 135.58, 130.08, 129.48, 128.0, 121.87, 120.57, 20.82.
EIMS m=z (%) 322 (MHþ, 12), 321 (Mþ., 72), 240 (12), 216 (9), 106 (Mþ.– ArSO,
100). Anal. calcd. for C13H11N3O5S: C, 48.56; H, 3.43; N, 13.08. Found: C, 48.58;
H, 3.44; N, 13.05.
N-(2,4,6-Trimethylphenyl)-2,4-dinitrobenzenesulfinamide
(4a). Mp
133 ꢁC; FTIR (KBr) nmax (cmꢀ1) 3035, 2367, 1597, 1541, 1479, 1347, 1105, 927,
1
910, 833, 816. H NMR (400 MHz, CDCl3) d 8.96 (d, J ¼ 2.2 Hz, 1H), 8.64 (dd,
J ¼ 8.5, 2.2 Hz, 1H), 8.49 (d, J ¼ 8.5 Hz, 1H), 6.84 (s, 2H), 5.68 (s, 1H), 2.23 (s,
3H), 2.21 (s, 6H). 13C NMR (100 MHz, CDCl3) d 149.64, 149.04, 146.20, 136.97,
134.87, 131.76, 129.82, 128.53, 128.04, 120.36, 20.80, 18.88. EIMS m=z (%) 349
(Mþ., 22), 215 (Mþ.– ArNH, 10), 134 (Mþ.– ArSO, 100). Anal. calcd. for C15H15
N3O5S: C, 51.58; H, 4.30; N, 12.03. Found: C, 51.55; H, 4.33; N, 12.01.
Compounds 5a–18a. Compounds 5a–18a have been reported previously, and
each was identified by comparison of actual and literature melting points and=or
spectral data, as follows. 5a (mp 90 ꢁC; lit.[24] 88–89 ꢁC), 6a (colorless oil[38]), 7a
(mp 52–54 ꢁC; lit.[39] 50–52 ꢁC), 8a (mp 76–77 ꢁC; lit.[39] 77–79 ꢁC), 9a (mp 126 ꢁC;
lit.[24] 128 ꢁC), 10a (colorless oil[13]), 11a (orange oil[13]), 12a (colorless oil[40]), 13a
(mp 76–78 ꢁC; lit.[13] 75–76 ꢁC), 14a (colorless liquid24), 15a (mp 106–108 ꢁC; lit.[24]
105–106 ꢁC), 16a (mp 88–90 ꢁC; lit.[24] 88–89 ꢁC), 17a (mp 114 ꢁC; lit.[24] 116–
118 ꢁC), and 18a (colorless oil[13]).
ACKNOWLEDGMENT
Financial support from Korea Advanced Institute of Science and Technology
(KAIST) is gratefully acknowledged.
REFERENCES
1. (a) Carren˜a, M. C. Applications of sulfoxides to asymmetric synthesis of biologically
active compounds. Chem. Rev. 1995, 95, 1717–1760, and references therein; (b) Anderson,
K. K. In The Chemistry of Sulphones and Sulphoxides; S. Patai, Z. Rappoport, C. J. M.
Stirling (Eds.); John Wiley & Sons: New York, 1988; pp. 55–94; (c) Walker, A. J.